RU2014151103A - APPLICATION OF COMPOUNDS OF THE CLASS OF 1,3,4-THIADIAZIN AND THEIR PHARMACEUTICAL COMPOSITION WITH ASCORBIC ACID AS A MEANS OF CORRECTION OF EXPERIMENTAL ALLOXAN SUGAR DIABETES - Google Patents
APPLICATION OF COMPOUNDS OF THE CLASS OF 1,3,4-THIADIAZIN AND THEIR PHARMACEUTICAL COMPOSITION WITH ASCORBIC ACID AS A MEANS OF CORRECTION OF EXPERIMENTAL ALLOXAN SUGAR DIABETES Download PDFInfo
- Publication number
- RU2014151103A RU2014151103A RU2014151103A RU2014151103A RU2014151103A RU 2014151103 A RU2014151103 A RU 2014151103A RU 2014151103 A RU2014151103 A RU 2014151103A RU 2014151103 A RU2014151103 A RU 2014151103A RU 2014151103 A RU2014151103 A RU 2014151103A
- Authority
- RU
- Russia
- Prior art keywords
- correction
- class
- compounds
- pharmaceutical composition
- ascorbic acid
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Abstract
Применение соединений класса 1,3,4-тиадиазина и их фармацевтической композиции с аскорбиновой кислотой в качестве средства коррекции экспериментального аллоксанового сахарного диабетаThe use of compounds of the class 1,3,4-thiadiazine and their pharmaceutical composition with ascorbic acid as a means of correction of experimental alloxan diabetes
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2014151103/15A RU2597764C2 (en) | 2014-12-16 | 2014-12-16 | Use of compounds of 1,3,4-thiadiazine class as agent for correction of experimental alloxan diabetes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2014151103/15A RU2597764C2 (en) | 2014-12-16 | 2014-12-16 | Use of compounds of 1,3,4-thiadiazine class as agent for correction of experimental alloxan diabetes |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2014151103A true RU2014151103A (en) | 2016-07-10 |
RU2597764C2 RU2597764C2 (en) | 2016-09-20 |
Family
ID=56372537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2014151103/15A RU2597764C2 (en) | 2014-12-16 | 2014-12-16 | Use of compounds of 1,3,4-thiadiazine class as agent for correction of experimental alloxan diabetes |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2597764C2 (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19502699A1 (en) * | 1995-01-28 | 1996-08-01 | Merck Patent Gmbh | Arylalkyl-thiadiazinones |
RU2152943C1 (en) * | 1995-12-28 | 2000-07-20 | Проктер энд Гэмбл Компани | Pharmaceutically acceptable salts of substituted 6h-1,3,4- -thiadiazine-2-amines and their pharmaceutical compositions |
RU2157808C2 (en) * | 1995-12-28 | 2000-10-20 | Проктер энд Гэмбл Компани | Substituted 6r-1,3,4-thiadiazine-2-amines and pharmaceutical composition thereof |
EP1463509A1 (en) * | 2001-10-31 | 2004-10-06 | MERCK PATENT GmbH | Type 4 phosphodiesterase inhibitors and uses thereof |
RU2364591C1 (en) * | 2008-01-09 | 2009-08-20 | Государственное образовательное учреждение высшего профессионального образования "Пермская государственная фармацевтическая академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО ПГФА Росздрава) | Bis{3-phenyl-1-[2-(5-ethyl-1,3,4-thiadiazolyl)]carboxamido-1,3-propanedionato}cadmium, possessing hypoglycemic activity |
RU2458060C2 (en) * | 2009-05-22 | 2012-08-10 | Государственное образовательное учреждение высшего профессионального образования "Уральский государственный технический университет - УПИ имени первого Президента России Б.Н. Ельцина" | 5-(4'-hydroxyphenyl)-and 5-(2',5'-dihydroxyphenyl)-6 h-1,3,4-thiadiazine-2-amines, hydrohalogenides inhibiting thrombocyte aggregation in intravenous introduction |
RU2447066C2 (en) * | 2010-04-15 | 2012-04-10 | Александр Леонидович Гинцбург | Pathogenic bacteria-inhibiting biologically active substances and method of inhibiting pathogenic bacteria type iii secretion |
-
2014
- 2014-12-16 RU RU2014151103/15A patent/RU2597764C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2597764C2 (en) | 2016-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016002455A1 (en) | Multispecific antibodies. | |
EA201890058A1 (en) | GLUCAGON DERIVATIVE AND COMPOSITION CONTAINING A LONGERLY ACTING CONJUGATE OF THIS DERIVATIVE | |
BR112016015706A2 (en) | compound, use of it and pharmaceutical composition | |
JP2014221779A5 (en) | ||
EA201691988A1 (en) | DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION | |
DK3357523T3 (en) | BLOOD PUMPS | |
DK3684439T3 (en) | BLOOD PUMPS | |
BR112016018455A2 (en) | compound, acid, medication, methods to prevent or treat obesity and diabetes mellitus and to inhibit an enteropeptidase, and, use of a compound. | |
CL2016001918A1 (en) | Heteroaryl amides as protein aggregation inhibitors | |
DK3518892T3 (en) | PHARMACEUTICAL FORMULATION CONTAINING AN INSULIN COMPOUND | |
EA201791454A1 (en) | DRUG FORMS FOR TRANSDERMAL ADMINISTRATION | |
EA201691982A1 (en) | 5,6-Disposable Pyridine-2-Carboxamides as Agonists of Cannabinoid Receptors | |
EA201790939A1 (en) | TRIAZOLO [4,5-d] Pyrimidine as an agonist of cannabinoid receptor type 2 | |
DK3554534T3 (en) | PHARMACEUTICAL COMPOSITION INCLUDING INSULIN | |
PH12017501084A1 (en) | Insulin glargine/lixisenatide fixed ratio formulation | |
EA201691983A1 (en) | Pyridine-2-amides suitable as agonists of CB2 | |
EA201491517A1 (en) | N-ETHYL-N-PHENYL-1,2-DIHYDRO-4,5-DIHYDROXI-1-METHYL-2-OXO-3-HINOLINKARBOXAMID, ITS PREPARATION AND APPLICATION | |
FR3033327B1 (en) | SOLID COMPOSITION OF CARBON NANOCHARGES FOR THE FORMULATIONS USED IN LEAD BATTERIES. | |
EA201990093A1 (en) | TWO COMPONENT COMPOSITION | |
RU2015136958A (en) | 2-aryl-2, 4-dihydroxy-2, 5-dihydro-3-heteryl-5-oxo-1n-pyrrol-1-yl-4-methylbelsolsulfanilamides having analgesic activity | |
RU2014151103A (en) | APPLICATION OF COMPOUNDS OF THE CLASS OF 1,3,4-THIADIAZIN AND THEIR PHARMACEUTICAL COMPOSITION WITH ASCORBIC ACID AS A MEANS OF CORRECTION OF EXPERIMENTAL ALLOXAN SUGAR DIABETES | |
EA202091403A1 (en) | 2-OXO-1-PYRROLIDINYLIMIDAZOTHIAZOLE DERIVATIVES | |
RU2011147626A (en) | AROMATIC BLOCK-COPOLYETHERSULPHONES | |
RU2013134779A (en) | 2- (5-Ethyl-1,3,4-thiadiazolyl) amide 2- (4-bromophenyl) -4-oxo-4-phenyl-2-butene acid, possessing analgesic activity | |
RU2014115406A (en) | APPLICATION 8- (TRIFFORMETHYL) BENZO [F] [1,2,3,4,5] PENTATIEPIN-6-AMINE AS ANTIDEPRESSANT |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20161217 |